Not applicableStudy completedNCT07498413What this trial is testingEpidemiology and Treatment of HR+/HER2- Breast Cancer in EnglandWho this might be right forBreast Cancer Novartis Pharmaceuticals 218,677
Early research (Phase 1)UnknownNCT05819684What this trial is testingSHR-4602 in Subjects With Advanced Malignant Solid TumorsWho this might be right forAdvanced Solid Tumor Suzhou Suncadia Biopharmaceuticals Co., Ltd. 133
Testing effectiveness (Phase 2)Study completedNCT00721630What this trial is testingNovel Capecitabine Dosing Schedule in Combination With Lapatinib, Based on the Norton-Simon Mathematical Method in Patients With HER2 Overexpressed/Amplified, Trastuzumab (Herceptin) -Refractory, Metastatic Breast CancerWho this might be right forBreast Cancer Memorial Sloan Kettering Cancer Center 24
Testing effectiveness (Phase 2)Ended earlyNCT00780000What this trial is testingClinical Trial of Intravenous Alvespimycin in Patients With Her2 Positive Breast CancerWho this might be right forBreast Cancer Bristol-Myers Squibb 4
Testing effectiveness (Phase 2)Study completedNCT02236000What this trial is testingA Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast CancerWho this might be right forBreast Cancer NSABP Foundation Inc 49
Testing effectiveness (Phase 2)UnknownNCT05020964What this trial is testingScreening Plasma HER2 Amplication by Digital PCR in Advanced Breast Cancer Patients Treated With Trastuzumab and PyrotinibWho this might be right forAdvanced Breast Cancer Chinese Academy of Medical Sciences 68
Not applicableStudy completedNCT02625935What this trial is testingProspective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer PatientsWho this might be right forBreast Cancer NanoString Technologies, Inc. 206
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07691489What this trial is testingTrastuzumab Deruxtecan (T-DXd) and Cetuximab in People With Colorectal CancerWho this might be right forColorectal CancerAdenocarcinoma of the ColonAdenocarcinoma of the Rectum Memorial Sloan Kettering Cancer Center 27
Not applicableUnknownNCT05773391What this trial is testingMechanism Exploration of Anti-HER-2 Small-molecule Tyrosine Kinase Inhibitor-related Diarrhea and Establishment of Prevention and Treatment Model(Measure)Who this might be right forBreast Cancer Sun Yat-sen University 100
Not applicableUnknownNCT06261918What this trial is testingTranscriptional and Epimetabolic Profile of Breast Carcinoma With Luminal or HER2+ or Locally Advanced Triple-negative Histotype in Patients With/Without Previous Clinical History of Metabolic SyndromeWho this might be right forBreast CancerMetabolic Syndrome Fondazione Policlinico Universitario Agostino Gemelli IRCCS 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT02734290What this trial is testingStandard of Care Chemotherapy Plus Pembrolizumab for Breast CancerWho this might be right forTriple Negative Breast Cancer Providence Health & Services 29
Testing effectiveness (Phase 2)Study completedNCT01216033What this trial is testingExploratory Study of Breast Cancer With ABY025Who this might be right forBreast Cancer Biomedical Radiation Sciences 7
Large-scale testing (Phase 3)Not Yet RecruitingNCT04736589What this trial is testingInetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM PathwayWho this might be right forBreast Cancer Peking Union Medical College 270
Testing effectiveness (Phase 2)Ended earlyNCT01290718What this trial is testingHerceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy.Who this might be right forBreast Cancer Hoffmann-La Roche 4
Large-scale testing (Phase 3)Looking for participantsNCT07190443What this trial is testingAdjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)Who this might be right forBreast CancerLocoregional RecurrenceAbemaciclib+1 more Japanese Foundation for Cancer Research 290
Large-scale testing (Phase 3)Study completedNCT02422615What this trial is testingStudy of Efficacy and Safety of LEE011 in Men and Postmenopausal Women With Advanced Breast Cancer.Who this might be right forAdvanced Breast Cancer Novartis Pharmaceuticals 726
Testing effectiveness (Phase 2)Looking for participantsNCT07540533What this trial is testingA Multicohort Study of Toripalimab in Combination With Investigator-Selected Chemotherapy for Advanced HER2-Negative Breast CancerWho this might be right forAdvanced Breast Cancer Henan Cancer Hospital 92
Very early researchLooking for participantsNCT06824155What this trial is testingHEAT Trial (HER2 Antibody Therapy With Lutetium-177)Who this might be right forHER2 Gene MutationAdvanced Solid Tumors Radiopharm Theranostics, Ltd 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02752685What this trial is testingPhase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast CancerWho this might be right forBreast Cancer NYU Langone Health 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT02311933What this trial is testingTamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerWho this might be right forRecurrent Breast CarcinomaStage III Breast Cancer AJCC v7Stage IIIA Breast Cancer AJCC v7+3 more National Cancer Institute (NCI) 81